Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
90 hedge funds and large institutions have $62.9M invested in Enzo Biochem, Inc. in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 27 reducing their positions, and 10 closing their positions.
346% more call options, than puts
Call options by funds: $58K | Put options by funds: $13K
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
15% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 27
3% more funds holding
Funds holding: 87 → 90 (+3)
34% less capital invested
Capital invested by funds: $94.8M → $62.9M (-$31.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$2.66M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.72M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$1.22M |
| 4 |
Renaissance Technologies
New York
|
+$882K |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$762K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
-$3.35M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$931K |
| 3 |
CCM
Corsair Capital Management
New York
|
-$856K |
| 4 |
BCCM
Blue Clay Capital Management
Minneapolis,
Minnesota
|
-$830K |
| 5 |
ClearBridge Investments
New York
|
-$730K |
ENZ Hedge Fund Activity: Q1 2015 in Review
90 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2015, worth a combined $62.9M — down 34% from $94.8M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ENZ positions and 10 closed out — a net gain of 3 holders — while 31 added to existing stakes and 27 trimmed.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $2.66M. The largest seller was Columbia Partners Investment Management, exiting entirely with an estimated $3.35M sold.
- 90 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2015, up from 87 in Q4 2014.
- Funds reported $62.9M of Enzo Biochem, Inc. stock for Q1 2015, down 34% quarter-over-quarter.
- 13 funds opened new Enzo Biochem, Inc. positions in Q1 2015 and 10 closed out, a net change of +3 holders.
- The largest Enzo Biochem, Inc. buyer in Q1 2015 was Manulife (Manufacturers Life Insurance), an estimated $2.66M added.
- The largest Enzo Biochem, Inc. seller in Q1 2015 was Columbia Partners Investment Management, an estimated $3.35M sold.
Based on aggregated 13F filings for Q1 2015.